Abstract
The determination of safety of intravenous anesthetics first agents used as intravenous anesthetics were barbiturates. Barbiturates with a duration of action appropriate to the requirements of surgery became available with the introduction of hexobarbital and thiopental (Volwiler and Tabern 1930; Miller et al. 1936). The studies with barbiturates were extended (Butler and Bush 1942; Christensen and Lee 1973). Intravenous anesthetics from other chemical groups were developed, such as acetamidoeugenol (Estil, Domenjoz 1959), steroid derivatives (Presuren = hydroxydione sodium, Laubach et al. 1955), alfaxolone (CT1341, Child et al. 1971), propanidid (Epontol, Goldenthal 1971), ketamine (CI-581, Chen et al. 1966; Reich and Silvay 1989), etomidate (Janssen et al. 1975), propofol (ICI 35868, Glenn 1980), and midazolam (Pieri 1983; Reilly and Nimmo 1987).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References and Further Reading
Antognini JF, Eisele PH (1993) Anesthetic potency and cardiopulmonary effects of enflurane, halothane, and isoflurane in goats. Lab Anim Sci 43:607–610
Borkowski GL, Dannemann PJ, Russel GB, Lang CM (1990) An evaluation of three intravenous regimens in New Zealand rabbits. Lab Anim Sci 40:270–276
Büch H, Butello W, Neurohr O, Rummel W (1968) Vergleich von Verteilung, narkotischer Wirksamkeit und metabolischer Elimination der optischen Antipoden von Methylphenobarbital. Biochem Pharmacol 17:2391–2398
Büch H, Grund W, Buzello W, Rummel W (1969) Narkotische Wirksamkeit und Gewebsverteilung der optischen antipoden des pentobarbitals bei der ratte. Biochem Pharmacol 18:1005–1009
Butler TC, Bush MT (1942) Anesthetic potency of some new derivatives of barbituric acid. Proc Soc Exp Biol Med 50:232–243
Cervin A, Lindberg S (1998) Changes in mucociliary activity may be used to investigate the airway-irritating potency of volatile anaesthetics. Br J Anaesth 80:475–480
Chaves AA, Dech SJ, Nakayama T et al (2003) Age and anesthetic effects on murine electrocardiography. Life Sci 72:2401–2412
Chen G, Ensor CR, Bohner B (1966) The neuropharmacology of 2-(o-chlorophenyl)-2-methylaminocyclohexanone hydrochloride. J Pharm Exp Ther 152:332–339
Child KJ, Currie JP, Davis B et al (1971) The pharmacological properties in animals of CT1341 – a new steroid anaesthetic agent. Br J Anaesth 43:2–24
Christensen HD, Lee IS (1973) Anesthetic potency and acute toxicity of optically active di-substituted barbituric acids. Toxicol Appl Pharmacol 26:495–503
Davis NL, Nunnally RL, Malinin TI (1975) Determination of the minimal alveolar concentration (MAC) of halothane in the white New Zealand rabbit. Br J Anesthesiol 47:341–345
Domenjoz R (1959) Anaesthesist 8:16
Doquier MA, Lavand’homme P, Ledermann C et al (2003) Can determining the minimum alveolar anesthetic concentration of volatile anesthetic be used as an objective tool to assess antinociception in animals? Anesth Analg 97:1033–1039
Eger EI II, Saidman LJ, Brandstater B (1965) Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiol 26:756–763
Eger EI II, Johnson BH, Weiskopf RB et al (1988) Minimum alveolar concentration of I-653 and isoflurane in pigs. Anaesth Analg 67:1174–1176
Eger EI II, Ionescu P, Laster MJ et al (1999) Minimum alveolar anesthetic concentration of fluorinated alkanols in rats: relevance to theories of narcosis. Anesth Analg 88:867–876
Eger EI II, Xing Y, Laster M et al (2003) Halothane and isoflurane have additive minimum alveolar concentration (MAC) effects in rats. Anesth Analg 96:1350–1353
Fang Z, Gong D, Ionescu P et al (1997) Maturation decreases ethanol minimum alveolar anesthetic concentration (MAC) more than desflurane MAC in rats. Anaesth Analg 84:852–858
Fukuda H, Hirabayashi Y, Shimizu R et al (1996) Sevoflurane is equivalent to isoflurane for attenuating bupivacaine-induced arrhythmias and seizures in rats. Anesth Analg 83:570–573
Glenn JB (1980) Animal studies of the anesthetic activity of ICI 35868. Br J Anaesth 52:731–742
Goldenthal EI (1971) A compilation of LD50 values in newborn and adult animals. Toxicol Appl Pharmacol 18:185–207
Gong D, Fang Z, Ionescu P et al (1998) Strain minimally influences anesthetic and convulsant requirements of inhaled compounds in rats. Anesth Analg 87:963–966
Hall RI, Murphy MR, Hug CC (1987) The enfluorane sparing effect of sufentanil in dogs. Anesthesiol 67:518–525
Hanagata K, Matsukawa T, Sessler DI et al (1995) Isoflurane and sevoflurane produce a dose-dependent reduction in the shivering threshold in rabbits. Anesth Analg 81:581–584
Hashimoto H, Imamura S, Ikeda K, Nakashima M (1994) Electrophysiological effects of volatile anesthetics, sevoflurane and halothane, in a canine myocardial infarction model. J Anesth 8:93–100
Hashimoto Y, Hirota K, Ohtomo N et al (1996) In vivo direct measurement of the bronchodilating effect of sevoflurane using a superfine fiber-optic bronchoscope: comparison with enflurane and halothane. J Cardiothorac Vasc Anesth 10:213–216
Hirano M, Fujigaki T, Shibata O, Sumikawa K (1995) A comparison of coronary hemodynamics during isoflurane and sevoflurane anesthesia in dogs. Anesth Analg 80:651–656
Hisaka Y, Ohe N, Takase K, Ogasawara S (1997) Cardiopulmonary effects of sevoflurane in cats: comparison with isoflurane, halothane, and enflurane. Res Vet Sci 63:205–210
Ide T, Sakurai Y, Aono M, Nishino T (1998) Minimum alveolar anesthetic concentrations for airway occlusion in cats: a new concept of minimum alveolar anesthetic concentration-airway occlusion response. Anaesth Analg 86:191–197
Janssen PAJ, Niemegeers CJE, Marsboom RPH (1975) Etomidate, a potent non-barbiturate hypnotic. intravenous etomidate in mice, rats, guinea pigs, rabbits and dogs. Arch Int Pharmacodyn 214:92–132
Johnson RA, Striler E, Sawyer DC, Brunson DB (1998) Comparison of isoflurane with sevoflurane for anesthesia induction and recovery in adult dogs. Am J Vet Res 59:478–481
Kanaya N, Kawana S, Tsuchida H et al (1998) Comparative myocardial depression of sevoflurane, isoflurane, and halothane in cultured neonatal rat ventricular myocytes. Anesth Analg 67:1041–1047
Kashimoto S, Furuya A, Nonoka A et al (1997) The minimum alveolar concentration of sevoflurane in rats. Eur J Anesthesiol 14:359–361
Kataoka Y, Manabe M, Takimoto E et al (1994) Negative inotropic effects of sevoflurane, isoflurane, enflurane and halothane in canine blood-perfused papillary muscles. Anesth Resusc 30:73–76
Kissin I, Morgan PL, Smith LR (1983) Comparison of isoflurane and halothane safety margins in rats. Anesthesiol 58:556–561
Kissin I, Kerr CR, Smith LR (1984) Morphine-halothane interaction in rats. Anesthesiol 60:553–561
Korkmaz S, Wahlström G (1997) The EEG burst suppression threshold test to determine the CNS sensitivity to intravenous anesthetics in rats. Brain Res Prot 1:378–384
Krantz JC Jr, Carr CJ, Forman SE et al (1941) Anesthesia. IV. The anesthetic action of cyclopropylethyl ether. J Pharmacol Exp Ther 72:233–244
Krantz JCJ, Carr CJ, Lu G, Bell FK (1953) Anesthesia. XL. The anesthetic action of trifluoroethyl vinyl ether. J Pharm Exp Ther 108:488–495
Laubach GD, Pan SY, Rudel HW (1955) Steroid anesthetic agent. Science 122:78
Mazzeo AJ, Cheng EY, Bosnjak ZJ et al (1996) Differential effects of desflurane and halothane on peripheral airway smooth muscle. Br J Anaesth 76:841–846
McMurphy RM, Hodgson DS (1996) Cardiopulmonary effects of desflurane in cats. Am J Vet Res 57:367–370
Merkel G, Eger EI II (1963) A comparative study of halothane and halopropane anesthesia. Anesthesiol 24:346–357
Miller E, Munch JC, Crossley FS, Hartung WH (1936) J Am Chem Soc 58:1090
Mitsuhata H, Saitoh J, Shimizu R et al (1994) Sevoflurane and isoflurane protect against bronchospasm in dogs. Anesthesiol 81:1230–1234
Murdock HR (1969) Anesthesia in the rabbit. Fed Proc 28:1510–1516
Murphy MR, Hug CC (1982) The anesthetic potency of fentanyl in terms of its reduction of enflurane MAC. Anesthesiol 57:485–488
Mutoh T, Nishimura R, Kim HY et al (1997) Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 58:885–890
Novalija E, Hogan QH, Kulier AH et al (1998) Effects of desflurane, sevoflurane and halothane on postinfarction spontaneous dysrhythmias in dogs. Acta Anaesthesiol Scand 42:353–357
Ohmura S, Ohta T, Yamamoto K, Kobayashi T (1999) A comparison of the effects of propofol and sevoflurane on the systemic toxicity of intravenous bupivacaine in rats. Anesth Analg 88(1):155–159
Peeters ME, Gil D, Teske E et al (1988) Four methods for general anesthesia in rabbits: a comparative study. Lab Animals 22:355–360
Pieri L (1983) Preclinical pharmacology of midazolam. Br J Clin Pharmacol 16:17S–27S
Quasha AL, Eger EI II, Tinker JH (1980) Determination and applications of MAC. Anesthesiol 53:315–334
Regan MJ, Eger EI II (1967) Effect of hypothermia in dogs on anesthetizing and apneic doses of inhalation agents. Determination of the anesthetic index (Apnea/MAC). Anesthesiol 28:689–700
Reich DL, Silvay G (1989) Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 36:186–197
Reilly CS, Nimmo WS (1987) New intravenous anaesthetics and neuromuscular blocking drugs. Drugs 34:98–135
Robbins BH (1946) Preliminary studies of the anesthetic activity of fluorinated hydrocarbons. J Pharmacol Exp Ther 86:197–204
Saeki Y, Hasegawa Y, Shibamoto T et al (1996) The effects of sevoflurane, enflurane, and isoflurane on baroreceptor-sympathetic reflex in rabbits. Anesth Analg 82:342–348
Saidman LJ, Eger EI II (1964) Effect of nitrous oxide and narcotic premedication on the alveolar concentration of halothane required for anesthesia. Anesthesiol 25:302–306
Salmempera M, Wilson D, Szlam F, Hugg CCJ (1992) Anesthetic potency of the opioid GI 87084B in dogs. Anesthesiology 77:A368
Seifen E, Seifen AB, Kennedy RH et al (1987) Comparison of cardiac effects of enflurane, isoflurane, and halothane in the dog heart-lung preparation. J Cardiothor Anesth 1:543–553
Selgrade MK, Gilmour MI (2010) Suppression of pulmonary host defenses and enhanced susceptibility to respiratory bacterial infection in mice following inhalation exposure to trichloroethylene and chloroform. J Immunotoxicol 7(4):350–356
Soma LR, Terney WJ, Hogan GK, Satoh N (1995) The effects of multiple administrations of sevoflurane to cynomolgus monkeys: clinical pathologic, hematologic and pathologic study. Anesth Analg 81:347–352
Sonner JM (2002) Issues in the design and interpretation of minimum alveolar anesthetic concentration (MAC) studies. Anesth Analg 95:609–614
Steffey EP, Howland D (1978) Potency of enflurane in dogs: comparison with halothane and isoflurane. Am J Vet Res 39:573–577
Stirt JA, Berger JM, Roe SD, Ricker SM, Sullivan SF (1981) Safety of enflurane following administration of aminophylline in experimental animals. Anesth Analg 60(12):871–873
Van Poznak A, Artusio FJ (1960a) Anesthetic properties of a series of fluorinated compounds. I. Fluorinated hydrocarbons. Toxicol Appl Pharmacol 2:363–373
Van Poznak A, Artusio FJ (1960b) Anesthetic properties of a series of fluorinated compounds. II. Fluorinated ethers. Toxicol Appl Pharmacol 2:363–373
Volwiler EH, Tabern DL (1930) J Am Chem Soc 52:1676
Waizer PR, Baez S, Orkin LR (1973) A method for determining minimum alveolar concentration of anesthetic in the rat. Anesthesiol 39:394–397
White PF, Johnston RR, Eger EI II (1974) Determination of anesthetic requirement in rats. Anesthesiol 40:52–57
Wolfson B, Dorsch SE, Kuo TS, Siker ES (1972) Brain anesthetic concentration – a new concept. Anesthesiol 36:176–179
Wolfson B, Kielar CM, Lake C et al (1973) Anesthetic index – a new approach. Anesthesiol 38:583–586
Zhou JX, Luo NF, Liang XM, Liu J (2006) The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth Analg 102(1):129–134
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Arendt-Nielsen, L. (2013). Safety of Intravenous and Inhalation Anesthetics. In: Vogel, H.G., Maas, J., Hock, F.J., Mayer, D. (eds) Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-25240-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-25240-2_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25239-6
Online ISBN: 978-3-642-25240-2
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences